Results 171 to 180 of about 4,984,276 (289)

Pulmonary arterial hypertension exacerbated by ruxolitinib [PDF]

, 2015
Harrison, C, Howard, L, Low, AT, Tulloh, RMR   +3 more
core   +2 more sources

Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis

, 2013
Roberta Zini, Ruggiero Norfo, Valentina Pennucci, Elisa Bianchi, Simona Salati, Paola Guglielmelli, Andrea Bisognin, Vittorio Rosti, Daniela Pietra, Silvia Salmoiraghi, Costanza Bogani, Tiziana Fanelli, Samantha Ruberti, Giorgia Sacchi, Zelia Prudente, Giovanni Barosi, Mario Cazzola, Alessandro Rambaldi, Stefania Bortoluzzi, Sérgio Ferrari, Enrico Tagliafico, Alessandro M. Vannucchi, Rossella Manfredini   +22 more
openalex   +2 more sources

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations [PDF]

, 2016
Barbui, T, Barosi, G, Birgegård, G, Cervantes, F, Griesshammer, M, Harrison, C., Hehlmann, R, Kiladjian, J-J, Kröger, N, Marchetti, M, McMullin, M F, Passamonti, F, Vannucchi, A   +12 more
core   +1 more source

A Review of the Pathological and Molecular Diagnosis of Primary Myelofibrosis. [PDF]

Cancers (Basel)
Shao R, Ryder C, Wang L, Zhang H, Moscinski L, Martin M, Shebes M, Li JY, Song J.   +8 more
europepmc   +1 more source

Role of TGF‐β1/miR‐382‐5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis [PDF]

, 2018
Chiara Rossi, Roberta Zini, Sebastiano Rontauroli, Samantha Ruberti, Zelia Prudente, Greta Barbieri, Elisa Bianchi, Simona Salati, Elena Genovese, Niccolò Bartalucci, Paola Guglielmelli, Enrico Tagliafico, Vittorio Rosti, Giovanni Barosi, Alessandro M. Vannucchi, Rossella Manfredini, the AGIMM (AIRC‐Gruppo Italiano Malattie Mieloproliferative) investigators   +16 more
openalex   +1 more source

Triple-negative primary myelofibrosis: a comparative analysis of phenotype, genotype, and outcome. [PDF]

Blood Cancer J
Bashir YA, Abdelrheem AA, Abdelmagid M, Reichard KK, He R, Zepeda Mendoza CJ, Pardanani A, Gangat N, Tefferi A.   +8 more
europepmc   +1 more source

[Fibrosis-driving cells in patients with primary myelofibrosis and myelodysplastic syndromes with myelofibrosis].

, 2020
Yanling Cai, P H Zhang, Liwei Fang, J Q Liu, B Li, Zefeng Xu, T J Qin, Zhijian Xiao   +7 more
openalex   +2 more sources

Spectrum of Kidney Biopsy Findings in a Patient With Primary Myelofibrosis. [PDF]

Kidney Int Rep
Dzedzik S, Alobeid B, Reddy S, D'Agati VD.   +3 more
europepmc   +1 more source

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial [PDF]

, 2017
DiPersio, John F, et al,
core   +1 more source

Application of Cytostatic Therapy in Patients with Primary Myelofibrosis in Young Age

, 2022
Abdiev Kattabek Makhmatovich, Akhmedov Khusan Isrofilovich   +1 more
openalex   +1 more source